Clinical Trials

Carcinoma, Non-Small-Cell Lung

NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Unknown

4,724 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02076477 2020-03-17

OITROLC

420 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03624309 2020-01-07

Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer

84 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04023617 2019-07-17

A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC

72 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03726736 2019-06-07

ACWDVDFPTAN

97 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03732001 2018-11-28

ALTER-L024

Carcinoma, Non-Small-Cell Lung

NCT03750916 2018-11-26

ACDFNSNSCLC

46 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03735264 2018-11-08

ACDFNSCLC

46 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03407300 2018-09-13

A Safety and Efficacy Trial of Docetaxel With or Without XH1 in Non-small Cell Lung Cancer (NSCLC) Patients

Carcinoma, Non-Small-Cell Lung

NCT03654027 2018-08-31

Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLC

84 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02450656 2018-08-27

M14AFS

320 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT02884479 2018-04-25

An Open-Label Phase I/II Clinical Study of PT-112 in Combination With Docetaxel in Subjects With Advanced Solid Tumor in a Phase I Dose Escalation Study and in Subjects With Non-Small Cell Lung Cancer (NSCLC) in a Phase II Dose Confirmation Study

75 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02134990 2018-04-18

Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer

20 enrolled

Phase EARLY_PHASE1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02568033 2017-01-31

Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer

22 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01771289 2016-09-27

Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC

50 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01803503 2016-06-22

Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Stomach Neoplasms

NCT02780778 2016-05-23

Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer

Phase 2/3 Unknown

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02031601 2016-03-29

TCL-1

Phase 4 Unknown

250 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02037997 2016-02-23

Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC

Carcinoma, Non-Small-Cell Lung

NCT02643407 2015-12-31

Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer

488 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT01424709 2014-09-25

BRAVO

120 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02191059 2014-07-31

Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT02036359 2014-01-15

Oncology

76 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00514293 2014-01-10

Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

39 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00030641 2014-01-06

Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00006215 2013-12-19

Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00022022 2013-12-18

Docetaxel in Treating Patients With Non-Small Cell Lung Cancer

200 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00003562 2013-12-04

Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

38 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00004264 2013-12-04

Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Drug-Related Side Effects and Adverse Reactions

NCT02001168 2013-12-04

Comparison of Postoperative Adjuvant Chemotherapy With/Without Rh-endostatin on Non-small Cell Lung Cancer in PhaseⅠB

392 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00989690 2013-08-12

Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer

275 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01755923 2012-12-24

Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC

Carcinoma, Non-Small-Cell Lung

NCT01746277 2012-12-10

Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs Therapy

Carcinoma, Non-Small-Cell Lung

NCT00637910 2012-02-24

TAILOR

850 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01497041 2011-12-22

A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment

35 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Large Cell

NCT00083083 2011-03-01

Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer

250 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00736814 2011-02-24

First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

117 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01192230 2010-09-16

Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01131429 2010-05-27

A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations